Concepedia

Uwe Reusch

UR

39

Publications

2.6K

Citations

29

H-Index

1990

Active since

Affiliations

Affimed Therapeutics (Germany)(Current)

University of the Witwatersrand

Ludwig-Maximilians-Universität München

German Cancer Research Center

Heidelberg University

Uwe Reusch is an author at Affimed Therapeutics (Germany) specializing in medicine, immunology, and cell biology.

Top concepts

Publications per year

1990–2022

39

Publications

39

Natural Killer Cells Activated by MHC Class ILow Targets Prime Dendritic Cells to Induce Protective CD8 T Cell Responses

Ralph Mocikat, Heidi Braumüller, Alain Gumy et al. · Immunity · 2003 · 418 citations · Full text

, , +8

A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation

Uwe Reusch, Walter Muranyi, Pero Lučin et al. · The EMBO Journal · 1999 · 248 citations · Full text

, , +9

A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30<sup>+</sup>tumor cells

Uwe Reusch, Carmen Burkhardt, Ivica Fucek et al. · mAbs · 2014 · 158 citations · Full text

, , +18

CD16A Activation of NK Cells Promotes NK Cell Proliferation and Memory-Like Cytotoxicity against Cancer Cells

Jens Pahl, Joachim Koch, Jana-Julia Götz et al. · Cancer Immunology Research · 2018 · 127 citations

A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19<sup>+</sup>tumor cells

Uwe Reusch, Johannes Duell, Kristina Ellwanger et al. · mAbs · 2015 · 125 citations · Full text

, , +17

Rows per page

1–5 of 39